ArticleCancer research2025
Selective Alanine Transporter Utilization Is a Therapeutic Vulnerability in ARID1A-Mutant Ovarian Cancer.
Hao Nie et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it
ArticleCancer research2025
Hao Nie et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.